A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

March 31, 2010

Conditions
Abdominal Aortic Aneurysm
Interventions
DEVICE

TriVascular Stent-Graft System

TriVascular Stent-Graft System

Trial Locations (7)

12208

Albany Medical College, Albany

15232

University of Pittsburgh Shadyside Hospital, Pittsburgh

19104

University of Pennsylvania Medical Center, Philadelphia

20007

Georgetown University Pasquerilla Healthcare, Washington D.C.

32610

University of Florida - Shands Hospital, Gainesville

33176

Miami Cardiac & Vascular Institute Baptist Hospital, Miami

90509

Harbor UCLA Medical Center, Torrance

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT00646048 - A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms | Biotech Hunter | Biotech Hunter